124 related articles for article (PubMed ID: 36655749)
1. IFNL3/4 polymorphisms as a two-edged sword: An association with COVID-19 outcome.
Matic S; Milovanovic D; Mijailovic Z; Djurdjevic P; Sazdanovic P; Stefanovic S; Todorovic D; Popovic S; Vitosevic K; Vukicevic V; Vukic M; Vukovic N; Milivojevic N; Zivanovic M; Jakovljevic V; Filipovic N; Baskic D; Djordjevic N
J Med Virol; 2023 Feb; 95(2):e28506. PubMed ID: 36655749
[TBL] [Abstract][Full Text] [Related]
2. Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
Matic S; Milovanovic D; Mijailovic Z; Djurdjevic P; Sazdanovic P; Stefanovic S; Todorovic D; Popovic S; Vitosevic K; Vukicevic V; Vukic M; Vukovic N; Milivojevic N; Zivanovic M; Jakovljevic V; Filipovic N; Djordjevic N; Baskic D
J Med Virol; 2023 Oct; 95(10):e29152. PubMed ID: 37812032
[TBL] [Abstract][Full Text] [Related]
3. The association between interferon lambda 3 and 4 gene single-nucleotide polymorphisms and the recovery of COVID-19 patients.
Rahimi P; Tarharoudi R; Rahimpour A; Mosayebi Amroabadi J; Ahmadi I; Anvari E; Siadat SD; Aghasadeghi M; Fateh A
Virol J; 2021 Nov; 18(1):221. PubMed ID: 34775984
[TBL] [Abstract][Full Text] [Related]
4. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
[TBL] [Abstract][Full Text] [Related]
5. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
[TBL] [Abstract][Full Text] [Related]
6. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
[TBL] [Abstract][Full Text] [Related]
7. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.
Knapp S; Zakaria Z; Hashem M; Zaghla H; Khakoo SI; Waked I; Thursz M; Abdelwahab SF
Hepatol Int; 2015 Apr; 9(2):251-7. PubMed ID: 25788203
[TBL] [Abstract][Full Text] [Related]
8. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
[TBL] [Abstract][Full Text] [Related]
9. Association of Interferon Lambda 3 and 4 Gene SNPs and Their Expression with COVID-19 Disease Severity: A Cross-Sectional Study.
Zahid W; Farooqui N; Zahid N; Ahmed K; Anwar MF; Rizwan-Ul-Hasan S; Hussain AR; Sarría-Santamera A; Abidi SH
Infect Drug Resist; 2023; 16():6619-6628. PubMed ID: 37840831
[TBL] [Abstract][Full Text] [Related]
10. The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection.
Jalilian S; Latifi SM; Makvandi M; Teimoori A; Azaran A; Parsanahad M; Kayedani G
Indian J Med Microbiol; 2017; 35(2):262-268. PubMed ID: 28681817
[TBL] [Abstract][Full Text] [Related]
11. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
[TBL] [Abstract][Full Text] [Related]
13. The Impact of IFNλ4 on the Adaptive Immune Response to SARS-CoV-2 Infection.
Møhlenberg M; Monrad I; Vibholm LK; Nielsen SSF; Frattari GS; Schleimann MH; Olesen R; Kjolby M; Gunst JD; Søgaard OS; O'Brien TR; Tolstrup M; Hartmann R
J Interferon Cytokine Res; 2021 Nov; 41(11):407-414. PubMed ID: 34788130
[TBL] [Abstract][Full Text] [Related]
14. IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.
Eslam M; Leung R; Romero-Gomez M; Mangia A; Irving WL; Sheridan D; Spengler U; Mollison L; Cheng W; Bugianesi E; McLeod D; Zaitoun AM; Attino V; Goeltz D; Nattermann J; Douglas M; Booth DR; George J; Ahlenstiel G
J Hepatol; 2014 Aug; 61(2):235-41. PubMed ID: 24768758
[TBL] [Abstract][Full Text] [Related]
15. Demographics, clinical characteristics, IFNL3- and IFNL4- polymorphisms in a cohort of hepatitis C patients from Puerto Rico.
Morales-Vásquez L; Miranda-Avalo EI; Rodríguez-Medina JR; Quiñones-Badillo Y; Marqués-Lespier J; Muñoz-Acabá J; Pastrana R; Pérez-Cardona CM; Yamamura Y; Torres EA
P R Health Sci J; 2014 Dec; 33(4):177-83. PubMed ID: 25563035
[TBL] [Abstract][Full Text] [Related]
16. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
Murakawa M; Asahina Y; Kawai-Kitahata F; Nakagawa M; Nitta S; Otani S; Nagata H; Kaneko S; Asano Y; Tsunoda T; Miyoshi M; Itsui Y; Azuma S; Kakinuma S; Tanaka Y; Iijima S; Tsuchiya K; Izumi N; Tohda S; Watanabe M
J Med Virol; 2017 Jul; 89(7):1241-1247. PubMed ID: 28036111
[TBL] [Abstract][Full Text] [Related]
17. Association of IFNL3 and IFNL4 polymorphisms with hepatitis C virus infection in a population from southeastern Brazil.
de Seixas Santos Nastri AC; de Mello Malta F; Diniz MA; Yoshino A; Abe-Sandes K; Dos Santos SE; de Castro Lyra A; Carrilho FJ; Pinho JR
Arch Virol; 2016 Jun; 161(6):1477-84. PubMed ID: 26973228
[TBL] [Abstract][Full Text] [Related]
18. Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.
Wróblewska A; Bernat A; Woziwodzka A; Markiewicz J; Romanowski T; Bielawski KP; Smiatacz T; Sikorska K
Clin Exp Med; 2017 May; 17(2):225-232. PubMed ID: 27125837
[TBL] [Abstract][Full Text] [Related]
19. No association between IFNL3 (IL28B) genotype and response to peginterferon alfa-2a in HBeAg-positive or -negative chronic hepatitis B.
Wei L; Wedemeyer H; Liaw YF; Chan HL; Piratvisuth T; Marcellin P; Jia J; Tan D; Chow WC; Brunetto MR; Diago M; Gurel S; Morozov V; He H; Zhu Y; Wat C; Surujbally B; Thompson AJ
PLoS One; 2018; 13(7):e0199198. PubMed ID: 30016335
[TBL] [Abstract][Full Text] [Related]
20. Population Polymorphism of IFNL3 and IFNL4 Genes of Type 3 Interferon Associated with Spontaneous Clearance of Hepatitis C Virus in Representatives of Caucasian and Mongoloid Races.
Malov IV; Malov SI; Savilov ED; Gantulga D; Stepanenko LA; Ogarkov OB; Nyamkhuu D; Aitov KA; Nyamdawa P; Kolesnikov SI
Bull Exp Biol Med; 2016 Jul; 161(3):404-7. PubMed ID: 27492404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
